Literature DB >> 28989086

Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry.

Grazia Aleppo1, Peter Calhoun2, Nicole C Foster3, David M Maahs4, Viral N Shah5, Kellee M Miller2.   

Abstract

OBJECTIVE: To better understand the prevalence and impact of gastroparesis in the T1D Exchange clinic registry database.
METHODS: The analysis included 7107 adult participants with T1D across 45 sites (median age 46years. and median duration 24years). Linear and logistic regression models were used to assess the association of gastroparesis vs. no gastroparesis (obtained from medical record) with demographic characteristics, glycemic control and diabetes complications.
RESULTS: Among 7107 registry participants, 340 (4.8%) had a clinical diagnosis of gastroparesis. Females were more likely to have gastroparesis compared with males (5.8% vs. 3.5%, P<0.001). Participants with gastroparesis compared with those without gastroparesis were older (median age 49.4 vs. 45.3years, P<0.001), had a longer duration of T1D (median duration 32 vs. 23years, P<0.001), higher mean HbA1c (8.1% vs. 7.7% [65 vs. 61mmol/mol], P<0.001), more frequent severe hypoglycemia (25% vs. 11% with ≥1 event in the past 12months, P<0.001), lower socio-economic status, less likely to be using CGM and insulin pump and greater prevalence of microvascular and neuropathic complications than participants without gastroparesis.
CONCLUSION: Gastroparesis is associated with higher risk of severe hypoglycemia despite higher HbA1c levels than in T1D patients without gastroparesis. The increased presence of multiple long-term complications and overall poor glycemic control in these subjects emphasizes the need to establish diagnostic protocols for earlier diagnosis, achieve tighter glycemic control with more extensive use of insulin pumps and continuous glucose monitoring, and the need for wider availability of medical therapies for treatment of diabetic gastroparesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult; Complications; Diabetes management; Gastroparesis; Glycemic control; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28989086      PMCID: PMC7172031          DOI: 10.1016/j.jdiacomp.2017.08.014

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  22 in total

Review 1.  The diagnosis and work-up of the patient with gastroparesis.

Authors:  K Hornbuckle; J L Barnett
Journal:  J Clin Gastroenterol       Date:  2000-03       Impact factor: 3.062

Review 2.  'Gastric' hypoglycaemia--an important concept in diabetes management.

Authors:  M Horowitz; K L Jones; C K Rayner; N W Read
Journal:  Neurogastroenterol Motil       Date:  2006-06       Impact factor: 3.598

3.  Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R J Fraser; M Horowitz; A F Maddox; P E Harding; B E Chatterton; J Dent
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

Review 4.  Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gut       Date:  2010-09-25       Impact factor: 23.059

5.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

6.  Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.

Authors:  Adam D Farmer; Anne Grave Pedersen; Birgitte Brock; Poul Erik Jakobsen; Jesper Karmisholt; Sahar D Mohammed; S Mark Scott; Asbjørn Mohr Drewes; Christina Brock
Journal:  Diabetologia       Date:  2017-01-20       Impact factor: 10.122

7.  Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population.

Authors:  Rok Seon Choung; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

8.  Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with Type 1 diabetes.

Authors:  Kristoffer Kofod-Andersen; Lise Tarnow
Journal:  J Diabetes Complications       Date:  2012-03-28       Impact factor: 2.852

9.  Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.

Authors:  Adil E Bharucha; Barbara Batey-Schaefer; Patricia A Cleary; Joseph A Murray; Catherine Cowie; Gayle Lorenzi; Marsha Driscoll; Judy Harth; Mary Larkin; Marielle Christofi; Margaret Bayless; Nyra Wimmergren; William Herman; Fred Whitehouse; Kim Jones; Davida Kruger; Cathy Martin; Georgia Ziegler; Alan R Zinsmeister; David M Nathan
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

Review 10.  Type 1 diabetes and gastroparesis: diagnosis and treatment.

Authors:  William L Hasler
Journal:  Curr Gastroenterol Rep       Date:  2007-08
View more
  9 in total

1.  State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2019-02       Impact factor: 6.118

Review 2.  Gastroparesis: a turning point in understanding and treatment.

Authors:  Madhusudan Grover; Gianrico Farrugia; Vincenzo Stanghellini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

3.  Diabetic Gastroparesis.

Authors:  Adil E Bharucha; Yogish C Kudva; David O Prichard
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

4.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Richard I G Holt; J Hans DeVries; Amy Hess-Fischl; Irl B Hirsch; M Sue Kirkman; Tomasz Klupa; Barbara Ludwig; Kirsten Nørgaard; Jeremy Pettus; Eric Renard; Jay S Skyler; Frank J Snoek; Ruth S Weinstock; Anne L Peters
Journal:  Diabetologia       Date:  2021-12       Impact factor: 10.122

Review 5.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

6.  The Incidence of Erosive Esophagitis as a Complication of Pediatric Diabetic Ketoacidosis.

Authors:  Sungeeta Agrawal; Serife Uysal; Meghan Fredette; Lisa Swartz Topor; Shara R Bialo; Michael Herzlinger; Jason Shapiro; Linda K Snelling; Charlotte M Boney; Jose Bernardo Quintos
Journal:  Case Rep Endocrinol       Date:  2021-03-05

7.  Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy.

Authors:  Mette W Klinge; Nanna Sutter; Esben B Mark; Anne-Mette Haase; Per Borghammer; Vincent Schlageter; Sten Lund; Jesper Fleischer; Karoline Knudsen; Asbjørn M Drewes; Klaus Krogh
Journal:  J Neurogastroenterol Motil       Date:  2021-07-30       Impact factor: 4.924

Review 8.  A new look at brittle diabetes.

Authors:  Irl B Hirsch; Linda M Gaudiani
Journal:  J Diabetes Complications       Date:  2020-06-02       Impact factor: 2.852

9.  Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.

Authors:  Mohammad Z Asha; Sundos F H Khalil
Journal:  Sultan Qaboos Univ Med J       Date:  2019-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.